Analystreport

Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

Deciphera Pharmaceuticals, Inc.  (DCPH) 
Last deciphera pharmaceuticals, inc. earnings: 3/9 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: deciphera.com/investor-relations